Evidence map›Paper›PMID 35812379›Full record

ArticleFrontiers in immunology2022

Heterologous Expression and Evaluation of Novel

Roos M de Jong, Susheel K Singh, Karina Teelen, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Will J R Stone, Emily Locke, Jordan Plieskatt, Michael Theisen, Teun Bousema and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Roos M de JongDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Susheel K SinghCentre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Karina TeelenDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Marga van de Vegte-BolmerDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Geert-Jan van GemertDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Will J R StoneDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Emily LockePATH's Malaria Vaccine Initiative, Washington, DC, United States.
Jordan PlieskattPATH's Malaria Vaccine Initiative, Washington, DC, United States.
Michael TheisenCentre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Teun BousemaDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Matthijs M JoreDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Radboud University Nijmegen · NLU.S. President's Malaria Initiative · USLondon School of Hygiene & Tropical Medicine · GBRadboud University Medical Center · NLStatens Serum Institut · DKUniversity of Copenhagen · DK

Funding

Wellcome Trust 218676/Z/19/Z
6 · The paper itself

Abstract

Malaria transmission blocking vaccines (TBV) aim to induce antibodies that can interrupt

Indexed as

CulicidaeMalariaMalaria VaccinesAnimalsAntibodies, ProtozoanAntigensDrosophila melanogasterMicePlasmodium falciparumProtozoan ProteinsAntibodies, ProtozoanAntigensMalaria VaccinesProtozoan Proteinsdrosophila melanogaster S2 cellslactococcus lactismalariaplasmodium falciparumrecombinant expressiontransmission blocking vaccines

Identifiers

PMID35812379
PMCPMC9259988
OpenAlexW4283327395

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.